文献速递重症综合管理与镇静镇痛心脑血管急症

凝血功能动态变化对急性脑损伤患者孤立性远端下肢深静脉血栓发生与进展的预测价值

[The predictive value of dynamic changes of coagulation function for the occurrence and progression of isolated distal deep vein thrombosis of lower limbs in patients with acute brain injury].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2021-01-01
一句话结论重症急性脑损伤围术期患者中,术后5-7天D-二聚体动态升高可预测孤立性远端下肢深静脉血栓(IDDVT)的发生与进展,有助于指导床旁下肢静脉超声筛查。

该回顾性病例对照研究纳入2019年9月至2020年5月中国科学技术大学附属第一医院神经重症监护病房(NCCU)的164例围术期急性脑损伤(ABI)患者,分析IDDVT发生与进展的危险因素及凝血指标D-二聚体的预测价值。结果显示IDDVT发生率为61.6%、进展率为16.8%,近端DVT发生率为12.8%。多因素Logistic回归显示年龄>60岁、入院GCS>8、ICU停留>13天与IDDVT发生相关;性别、输注红细胞、脑疝与IDDVT进展相关。术后5-7天D-二聚体预测IDDVT的AUC为0.72,截断值5.4 mg/L;D-二聚体较NCCU第1天升高至3.9倍预测IDDVT进展的AUC为0.81。

要点

  • 术后2-4天起IDDVT组D-二聚体即显著高于无IDDVT组[4.1(2.3,8.0)vs. 2.4(1.7,3.4)mg/L],并持续至5-7天。
  • IDDVT进展组术后2-4天D-二聚体显著高于非进展组[11.2(4.7,20.0)vs. 3.7(2.1,6.8)mg/L],持续至7天。
  • 术后5-7天D-二聚体5.4 mg/L预测IDDVT的AUC为0.72,敏感度54.4%、特异度80.9%、阳性预测值84.5%。
  • D-二聚体在术后5-7天较NCCU第1天升高至3.9倍预测IDDVT进展,AUC为0.81,敏感度76.5%、特异度74.6%、阴性预测值93.0%。
  • 年龄>60岁(OR=3.43)、入院GCS>8(OR=0.35)、ICU停留>13天(OR=2.25)为IDDVT发生的危险因素。

适用人群与场景

  • 中国科学技术大学附属第一医院神经重症监护病房(NCCU)2019年9月至2020年5月收治的围术期急性脑损伤(ABI)患者,共164例;多数为老年[年龄60(51,69)岁]、男性[99例(60.4%)]、重症[入院GCS 6(5,8)分]。

诊断标准与关键阈值

  • IDDVT定义为下肢孤立性远端深静脉血栓;原文未给出具体超声诊断界值。
  • 术后5-7天D-二聚体截断值5.4 mg/L用于预测IDDVT发生(AUC 0.72,95%CI 0.64-0.80)。
  • D-二聚体在术后5-7天较NCCU第1天升高至3.9倍用于预测IDDVT进展(AUC 0.81,95%CI 0.71-0.88)。
  • 年龄截断值60岁用于预测IDDVT发生(AUC 0.68,95%CI 0.60-0.75)。

处置流程与药物剂量

  • 原文未提及具体的抗凝药物剂量、给药途径、频次或疗程;仅提及抗凝治疗比例为非进展组47.6%(40/84)、进展组94.1%(16/17)。
  • 建议依据D-二聚体动态变化(尤其术后5-7天)指导实施下肢深静脉超声检查。
  • 原文未提及具体的筛查时间表或超声复查频次。

红旗征与不能漏的情况

  • 脑疝:非进展组脑疝比例42.9%(38/84)高于进展组11.8%(2/17),原文将其列为IDDVT进展的相关因素(OR=0.18,95%CI 0.37-0.90)。
  • 输注红细胞:进展组输注红细胞比例29.4%(5/17)高于非进展组8.3%(7/84),原文列为IDDVT进展的相关因素(OR=6.50,95%CI 1.33-31.94)。

研究设计与关键结果

  • 研究类型:回顾性病例对照研究,单中心,样本量164例。
  • IDDVT发生率为61.6%(101例),进展率为16.8%(17例),近端DVT发生率为12.8%(21例)。
  • IDDVT发生危险因素:年龄>60岁(OR=3.43,95%CI 1.69-6.96,P=0.001)、入院GCS>8(OR=0.35,95%CI 0.17-0.76,P=0.008)、ICU停留>13天(OR=2.25,95%CI 1.08-4.70,P=0.031)。
  • IDDVT进展相关因素:性别(OR=0.19,95%CI 0.02-0.71,P=0.019)、输注红细胞(OR=6.50,95%CI 1.33-31.94,P=0.021)、脑疝(OR=0.18,95%CI 0.37-0.90,P=0.036)。
  • D-二聚体预测IDDVT:术后5-7天AUC 0.72(95%CI 0.64-0.80),截断值5.4 mg/L,敏感度54.4%、特异度80.9%、阳性预测值84.5%、阴性预测值48.1%。
  • D-二聚体升高至3.9倍预测IDDVT进展:AUC 0.81(95%CI 0.71-0.88),敏感度76.5%、特异度74.6%、阳性预测值41.9%、阴性预测值93.0%。

证据类型、等级与局限

  • 证据类型:回顾性病例对照研究(单中心)。
  • 局限:单中心、回顾性设计、样本量较小(164例),IDDVT进展组仅17例,结论需前瞻性验证。

对床旁实践的改变

  • 对围术期重症ABI患者,可在术后5-7天复查D-二聚体,若≥5.4 mg/L或较NCCU第1天升高至3.9倍,提示IDDVT发生或进展风险,可据此安排下肢深静脉超声。
  • 年龄>60岁、入院GCS>8、ICU停留>13天的患者IDDVT发生风险更高,应加强监测。
  • D-二聚体预测IDDVT进展的阴性预测值达93.0%,低值时有助于排除进展,但阳性预测值仅41.9%,不宜单独作为确诊依据。
  • 原文未提及该策略对死亡率或抗凝决策的改善,不能据此改变抗凝指征或剂量。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

OBJECTIVE: To analyze risk factors for the occurrence and progression of isolated distal deep vein thrombosis (IDDVT) of lower limbs, and to explore the predictive value of dynamic changes of coagulation index D-dimer on the occurrence and progression of IDDVT in acute brain injury (ABI) patients during perioperative period.

METHODS: A retrospective case-control study was conducted. Perioperative ABI patients admitted to department of neurocritical care unit (NCCU) of the First Affiliated Hospital of University of Science and Technology of China from September 2019 to May 2020 were enrolled. Patients' baseline characteristics, disease characteristics, treatment approaches, outcomes and coagulation function index at 1, 2-4, 5-7 and > 7 days post operation were analyzed between patients with IDDVT and patients with progressive IDDVT. Risk factors for IDDVT occurrence and progression were identified by multivariate Logistic regression. Receiver operating characteristic curve (ROC curve) were drawn to assess the predictive value of coagulation indexes for IDDVT occurrence and progression.

RESULTS: A total of 164 ABI patients were enrolled. Most of the patients were elderly [age was 60 (51, 69) years], male [99 cases (60.4%)], and severe cases [Glasgow coma score (GCS) at admission was 6 (5, 8)]. The rates of IDDVT occurrence and progression were 61.6% (101 cases) and 16.8% (17 cases), respectively, the rate of proximal deep venous thrombosis (DVT) was 12.8% (21 cases). Compared with the IDDVT group (101 patients), patients without IDDVT group were younger (years: 55±13 vs. 62±13), length of intensive care unit (ICU) stay were shorter (days: 12±6 vs. 15±7), body mass index (BMI) and GCS at admission were higher [59 patients, BMI (kg/m2): 23±5 vs. 19±8, GCS scores: 7±2 vs. 6±2], the differences were statistically significant (all P < 0.05). Compared with patients with IDDVT progression group, male patients were fewer [61.9% (52/84) vs. 88.2% (15/17)], the proportion of transfusion of red blood cell and anticoagulant therapy were lower [8.3% (7/84) vs. 29.4% (5/17) and 47.6% (40/84) vs. 94.1% (16/17)], the proportion of cerebral herniation was higher [42.9% (38/84) vs. 11.8% (2/17)] in patients without IDDVT progressive group. All of the differences were statistically significant (all P < 0.05). D-dimer were increased in two groups of whether IDDVT occurrence or not over time. D-dimer peaked on 5-7 days after surgery in IDDVT occurrence group, and then decreased. D-dimer peaked at > 7 days after surgery in patients without IDDVT. With time, D-dimer were increased in groups of whether IDDVT progression or not, both peaked at 5-7 days postoperation, and then decreased. Compared with non-IDDVTgroup, D-dimer was significantly increased in IDDVT group from 2-4 days after surgery [mg/L: 4.1 (2.3, 8.0) vs. 2.4 (1.7, 3.4), P < 0.05], and lasted until 5-7 days [mg/L: 5.5 (3.3, 11.4) vs. 3.9 (2.6, 5.8), P < 0.05]. Compared with IDDVT group, D-dimer was significantly increased in IDDVT progressive group from 2-4 days [mg/L: 11.2 (4.7, 20.0) vs. 3.7 (2.1, 6.8), P < 0.05], and lasted until 7 days [mg/L: 11.0 (3.0, 18.9) vs. 4.1 (2.6, 6.5), P < 0.05]. Multivariate Logistic regression analysis showed that age > 60 years [odds ratio (OR) = 3.43, 95% confidence interval (95%CI) was 1.69-6.96, P = 0.001], GCS score at admission > 8 (OR = 0.35, 95%CI was 0.17-0.76, P = 0.008), length of ICU stay > 13 days (OR = 2.25, 95%CI was 1.08-4.70, P = 0.031) were risk factors for IDDVT. Gender (OR = 0.19, 95%CI was 0.02-0.71, P = 0.019), transfusion of red blood cell (OR = 6.50, 95%CI was 1.33-31.94, P = 0.021), cerebral herniation (OR = 0.18, 95%CI was 0.37-0.90, P = 0.036) were risk factors for IDDVT profression. ROC curve analysis showed that age and D-dimer at 5-7 days were predicators of IDDVT [the area under curve ROC (AUC) were 0.68 and 0.72, 95%CI were 0.60-0.75 and 0.64-0.80, both P value were 0.000 1]. When the cut-off value of age was 60 years old and the D-dimer was 5.4 mg/L, the sensitivity were 60.6% and 54.4%, specificity were 71.2% and 80.9%, respectively, positive predictive value were 78.7%, 84.5%, negative predictive value were 51.2%, 48.1%, respectively. The elevation of D-dimer to 3.9 times at days 5-7 compared with day 1 of NCCU stay was a predicator of IDDVT progression (AUC = 0.81, 95%CI was 0.71-0.88, P = 0.000 1). The sensitivity, specificity, positive predictive value and negative predictive value were 76.5%, 74.6%, 41.9% and 93.0%, respectively.

CONCLUSIONS: IDDVT occurrence and progressiveare common in severe ABI patients during perioperative period. The dynamic change of D-dimer, especially at days 5-7, is a valuable predictor of IDDVT progressionin ABI patients, which is helpful for guiding implementation of deep vein ultrasound of lower limb.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Tang R, Gao Z, Du M, et al. [The predictive value of dynamic changes of coagulation function for the occurrence and progression of isolated distal deep vein thrombosis of lower limbs in patients with acute brain injury]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021. PMID: 34296693. doi:10.3760/cma.j.cn121430-20210323-00427

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。